BFA
GILD icon

Beaumont Financial Advisors’s Gilead Sciences GILD Stock Holding History

Beaumont Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
1,761
+74
+4% +$9.75K 0.01% 350
2026
Q1 		$235K Buy
+1,687
New +$236K 0.02% 332
2025
Q4 		– Sell
-2,130
Closed -$236K – 387
2025
Q3 		$236K Buy
2,130
+35
+2% +$3.98K 0.02% 359
2025
Q2 		$232K Buy
2,095
+10
+0.5% +$1.06K 0.02% 341
2025
Q1 		$234K Buy
+2,085
New +$215K 0.02% 330
2022
Q2 		– Sell
-6,278
Closed -$373K – 327
2022
Q1 		$373K Buy
6,278
+27
+0.4% +$1.73K 0.03% 243
2021
Q4 		$454K Buy
6,251
+117
+2% +$8.06K 0.03% 228
2021
Q3 		$428K Sell
6,134
-101
-2% -$7.1K 0.03% 222
2021
Q2 		$429K Hold
6,235
– – 0.03% 232
2021
Q1 		$403K Sell
6,235
-96
-2% -$6.19K 0.03% 224
2020
Q4 		$369K Sell
6,331
-388
-6% -$23.4K 0.03% 236
2020
Q3 		$425K Buy
6,719
+381
+6% +$26.4K 0.04% 208
2020
Q2 		$488K Buy
6,338
+132
+2% +$10.1K 0.05% 180
2020
Q1 		$464K Buy
+6,206
New +$429K 0.06% 149
2018
Q4 		– Sell
-4,134
Closed -$319K – 212
2018
Q3 		$319K Buy
+4,134
New +$312K 0.03% 181
2016
Q2 		– Sell
-17,125
Closed -$1.68M – 149
2016
Q1 		$1.68M Sell
17,125
-72,989
-81% -$6.58M 0.27% 74
2015
Q4 		$9.12M Buy
90,114
+21,914
+32% +$2.28M 1.5% 27
2015
Q3 		$7.99M Hold
68,200
– – 1.16% 37
2015
Q2 		$7.99M Buy
68,200
+50,525
+286% +$5.52M 1.16% 37
2015
Q1 		$1.73M Buy
17,675
+3,421
+24% +$347K 0.06% 89
2014
Q4 		$1.34M Buy
14,254
+12,055
+548% +$1.25M 0.06% 92
2014
Q3 		$234K Buy
+2,199
New +$215K 0.02% 146

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Beaumont Financial Advisors's GILD Position: Q2 2026 in Review

Beaumont Financial Advisors increased its Gilead Sciences (GILD) stake by 4.4% in Q2 2026, buying an estimated $9.75K and bringing the position to 1,761 shares worth $223K. The position accounts for 0.01% of the portfolio, ranked #350.

Beaumont Financial Advisors first reported a position in GILD in Q3 2014 and has held it in 22 quarters since. The position peaked at $9.12M in Q4 2015. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Beaumont Financial Advisors held 1,761 shares of Gilead Sciences worth $223K as of Q2 2026.
  • Beaumont Financial Advisors bought 74 Gilead Sciences shares in Q2 2026, an estimated $9.75K.
  • Gilead Sciences made up 0.01% of Beaumont Financial Advisors's portfolio in Q2 2026, its #350 holding.
  • Beaumont Financial Advisors first reported a position in Gilead Sciences in Q3 2014 and has held it in 22 quarters since.
  • Beaumont Financial Advisors's Gilead Sciences position peaked at $9.12M in Q4 2015.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Beaumont Financial Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.